A B S T R A C T Studies were conducted to ascertain the in vitro effect of 3,5,3'-triiodothyronine (T3) on the accumulation of the glucose analogue, 2-deoxyglucose (2-DG), by thymocytes freshly isolated from weanling rats. At a concentration of 1 ,uM, T3 stimulated the 15-min uptake of 3H-2-DG after cells had been exposed to T3 for only 30 min. Significant stimulation of 2-DG accumulation was produced by 1 nM T3, with increasing stimulation at doses ranging up to 10 ,uM. T3 did not alter the fraction of accumulated 2-DG that was phosphorylated, and kinetic studies indicated that its effect was associated with a significant increase in the apparent Vmax of 2-DG accumulation, but not the apparent Km. T3 also enhanced the accumulation by thymocytes of the nonmetabolized glucose analogue, 3-0-methylglucose (3-0-MG), an effect that was evidently the result of an increase in 3-0-MG transport into the cell, because it was seen in cells incubated with 3H-3-O-MG for only 30 s. The proportionate increase in 2-DG accumulation produced by T3 was not altered by preincubating cells with concentrations of puromycin or cycloheximide sufficient to reduce [3H]-leucine incorporation by 95%, and T3 over a period of >2 h had no effect on [3H]leucine incorporation itself.
A B S T R A C T Studies were conducted to ascertain the in vitro effect of 3,5,3'-triiodothyronine (T3) on the accumulation of the glucose analogue, 2-deoxyglucose (2-DG), by thymocytes freshly isolated from weanling rats. At a concentration of 1 ,uM, T3 stimulated the 15- min uptake of 3H-2-DG after cells had been exposed to T3 for only 30 min. Significant stimulation of 2-DG accumulation was produced by 1 nM T3, with increasing stimulation at doses ranging up to 10 ,uM. T3 did not alter the fraction of accumulated 2-DG that was phosphorylated, and kinetic studies indicated that its effect was associated with a significant increase in the apparent Vmax of 2-DG accumulation, but not the apparent Km. T3 also enhanced the accumulation by thymocytes of the nonmetabolized glucose analogue, 3-0-methylglucose (3-0-MG), an effect that was evidently the result of an increase in 3-0-MG transport into the cell, because it was seen in cells incubated with 3H-3-O-MG for only 30 s. The proportionate increase in 2-DG accumulation produced by T3 was not altered by preincubating cells with concentrations of puromycin or cycloheximide sufficient to reduce [3H]-leucine incorporation by 95%, and T3 over a period of >2 h had no effect on [3H]leucine incorporation itself.
These results indicate that T3 stimulates the uptake of sugars in rat thymocytes in vitro by an effect on their inward transport. The promptness of the effect and its failure to be inhibited during profound inhibition of protein synthesis further indicate that this effect of T3 is not mediated through a nuclear-dependent mechanism. Rather, the properties of this response, and of the increases in amino acid and 2-DG accumulation produced by T3 in other tissue preparations, strongly suggest that these effects of T3 are mediated at the level of cell membrane.
INTRODUCTION
Recent years have seen a great growth of interest in the primary mechanism of action of the thyroid hormones. The voluminous data that have resulted strongly suggest that the thyroid hormones exert a primary effect at the level of the cell nucleus (1) (2) (3) (4) (5) , and perhaps the mitochondrion as well (6) (7) (8) . In addition, evidence has grown that the thyroid hormones may also exert a direct effect that the level of the cell membrane. 3,5,3'-Triiodothyronine (T3)1 and other thyroactive materials have, for example, been shown to stimulate the in vitro accumulation of certain amino acids by chick embryo cartilage and rat thymocytes (9) (10) (11) , and, in the case of the rat thymocyte, this effect has been found after in vivo administration ofT3 (12) . In addition, in cultured chick embryo myocardial cells, T3 enhances cellular uptake of the glucose analogue, 2-deoxyn-glucose (2-DG) (13, 14) . All of these effects on substrate accumulation occur promptly and are independent of ongoing protein synthesis. In the present studies we demonstrate that the effect of T3 on cellular 2-DG uptake is not limited to the chick myocardium, but appears to be more general, because it occurs as well in the rat thymocyte, where it is also prompt and independent of new protein synthesis, and results from enhancement of the transport of 2-DG into the cell, rather than in increase in its phosphorylation.
METHODS
Thymocyte suspensions. Rats of the CD strain, ranging in age between 25 and 27 d, were purchased from Charles River Breeding Laboratories (Wilmington, Mass.) and were maintained for a maximum of 6 d before study on a diet of Purina laboratory chow (Ralston Purina Co., St. Louis, Mo.).
Thymocytes were then harvested according to the method described by Goldfine and co-workers (11) . Briefly, animals were killed by cervical dislocation, thymus glands were quickly removed and washed in ice-cold Krebs-Ringer 25 mM Tris buffer, pH 7.5. Tissues were then gently teased, and the thymocytes therey liberated were filtered through nylon mesh and centrifuged at 800 g for 5 min. The supernate was decanted and the cell pellet was resuspended in buffer. Thymocytes were counted in a hemocytometer and additional buffer was added to yield a final thymocyte concentration of45 x 106 cells/ml. 3 ml of the cold suspension was pipetted into siliconized Erlenmeyer flasks, and these were incubated during a 30-min equilibration period at 37°C in room air. Thereafter, preincubation or incubation periods, as indicated below, were initiated.
3H-2-DG uptake. Either at the beginning of incubation or, more commonly, after preincubation of cell suspensions with various agents, 3H-2-DG (8.26 Ci/mmol sp act)2 was added to the medium to a final concentration of 3 ,uCi/ml (0.36 ,.M). After specified periods, 200-1. aliquots were removed, pipetted into microtubes, and centrifuged in a Beckman microfuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) at 10,000 rpm for 20 s. The supernate was quickly removed by aspiration and the pellet was suspended in 100 ,ul of ice-cold 5% trichloroacetic acid (TCA). The entire suspension was quantitatively transferred to counting vials with the aid of Toluene-Triton X-100 (Rohm and Haas Co., Philadelphia, Pa.) scintillation counting fluid. Samples were counted in a betascintillation counter with automatic quench correction.
In preliminary experiments, uptake of 3H-2-DG was shown to be linear during at least the 1st h of incubation. Therefore, a 15-min period of incubation with 3H-2-DG was employed in all subsequent experiments.
[3-0-3H]Methylglucose uptake. In experiments to assess the effect ofT3 on the uptake ofthe nonmetabolized sugar, 3-0-methyl-D-glucose (3-0-MG), cells were prepared as above and were equilibrated and preincubated with or without T3 as in experiments with 3H-2-DG. At the end of preincubation periods, 3H-3-0-MG (3 uCi/ml; 80.8 Ci/mmol sp act) was added, and the incubation continued. At specified intervals thereafter, aliquots were removed and processed for measurement ofthe 3H content of the thymocytes as described above.
Corrections for occluded extracellularfluid. Consequently, in each experiment, parallel cell suspensions containing [3H]mannitol, rather than 3H-2-DG or 3H-3-0-MG, were incubated so that corrections for occluded extracellular fluid in the cell pellets could be made.
Phosphorylation of 2-DG. In experiments to determine the percentage of accumulated 3H-2-DG that had undergone phosphorylation within the thymocytes, cell suspensions were prepared, equilibrated, and preincubated with or without T3 according to the techniques described above. Media were then enriched with 3H-2-DG in concentrations ranging between 0.36 uLM and 8 mM. 15 min later, triplicate aliquots of 200 ,ul of suspension were removed for measurement of total 3H-2-DG uptake and duplicate 500-,ul aliquots were removed at the same time for fractionation of 3H-2-DG into phosphorylated and nonphosphorylated moieties. The latter suspensions were centrifuged, the cell pellets were dispersed into 5% cold TCA and were resedimented. Supernates were enriched with 2 mM 2-DG-6-phosphate carrier and were then brought to pH 7.0 with concentrated NaOH. Somogyi reagent (15) was added, and the mixture was centrifuged. Aliquots of the supernate were taken for measurement of nonphosphorylated 3H-2-DG, and the quantity of 3H-2-DG-6-phosphate calculated as the difference between total 3H in the cell pellet and 3H in the Somogyi supernate.
Control experiments in which a 5% solution of TCA was first enriched with [3H]glucose-6-phosphate and the foregoing procedure was then carried out revealed that 98% ofthe 3H was contained in the final precipitate.
Kinetics of 2-DG accumulation. In the experiments to assess the phosphorylation of 3H-2-DG described above, triplicate 200-,ul aliquots of cell suspension were removed 10 min after varying concentrations of 3H-2-DG had been added. Total 3H uptake was measured, and the data obtained were subjected to analysis.
Leucine incorporation. To assess the effect of T3 in vitro on leucine incorporation into thymocyte protein, cell suspensions were prepared and equilibrated in the standard manner, and were then preincubated with or without T3 for varying periods. Thereafter, [3H]leucine (84 Ci/mmol sp act) was added in a concentration of 1 ,uCi/ml, and incubations were continued for 30 min. The entire suspension was transferred to centrifuge tubes, cells were sedimented, resuspended in 3 ml of 5% cold TCA, resedimented, and washed twice again with 5% cold TCA. After a final centrifugation, the sediment was taken up in Toluene-Triton X-100 counting fluid and its content of 3H measured.
Statistical analyses. As appropriate to the experimental design, statistical analyses were performed with Student's t test, the paired t test, or by Dunnett's test (16) .
RESULTS
Latency of T3 effect. Initial experiments were conducted to determine whether T3 would influence the uptake of 2-DG by thymocytes, and, if so, how long a period of exposure of cells to T3 would be required. For these experiments, cells were incubated with T3 at a concentration of 1 ,uM, because this had been shown to enhance the accumulation of cycloleucine by thymocytes under similar in vitro conditions (11) . Control and T3-enriched thymocyte suspensions were preincubated for varying periods, after which 3H-2-DG was added and its uptake by the cells measured 15 min later.
As compared with values in corresponding controls, uptake of 3H-2-DG in specimens preincubated with T3 for 30, 60 , and 120 min was significantly increased in each of five individual experiments ( Fig. 1) . In specimens preincubated with T3 for 15 min, a significant increase in 3H-2-DG uptake was not seen in any of the five experiments; however, when mean values for control and T3-treated specimens of the five experiments were compared by the paired t test, a significant increase (P < 0.05) was demonstrable. Hence, at a concentration of 1 ,uM, a significant stimulatory effect of T3 on 2-DG accumulation by thymocytes was seen after cells have been exposed to the hormone for a total of only 30 min. In control specimens, the uptake of 2-DG remained constant after preincubation periods of from 15 to 30 min, increased slightly in cells preincubated for 1 h, and was substantially increased in cells preincubated for 2 h. Consequently, the percentage stimulation of 2-DG uptake produced by T3 was greatest in cells preincubated for 1 Kinetics of 2-DG accumulation. In the two experiCells were pre-ments described immediately above, the effect of T3 licated. 3H-2-DG on the kinetics of 2-DG accumulation was evaluated Aells measured 15 from data obtained 10 min after addition of varying -hose obtained in concentrations of 3H-2-DG. As in specimens incubated issels were incu-for 15 min, total accumulation of 2-DG was higher in )5) was present in T3-treated than in control specimens at all concentrations of 2-DG employed (P < 0.02) (Fig. 4) . Despite the (17) (18) (19) (20) . Values for apparent Vmax were significantly higher (P < 0.02), however, in T3-treated (3.91±0.25 ,umol/109 cells per 10 min) than in control (3.45±0.28 ,umol/109 cells per 10 min) groups.
3-0-MG accumulation. In each oftwo experiments, quadruplicate samples of thymocytes were preincubated with T3 (1 nM or 1 ,uM) for 1 h, after which 3H-3-0-MG was added and its cellular accumulation measured at intervals varying between 30 s and 30 min later. Three additional experiments were conducted in which the effect of T3 only on accumulation of3H-3-0-MG during 30 s was assessed. Analysis ofthe data revealed that 1 j,M T3 increased 3H-3-0-MG accumulation at all of the time intervals studied, and that 1 nM T3 did so at all except that 30-min interval. This was true whether data from individual experiments were analyzed or whether the results ofreplicate studies were pooled and analyzed together. As seen in Fig. 5 , the proportionate effect of both 1 ,uM and 1 nM decreased over the time that the cells were exposed to 3-0-MG.
[3H]Leucine incorporation. In four experiments, thymocytes were preincubated for 1 or 2 h in media either lacking T3 or containing T3 at concentrations of INCUBATION TIME (minutes) 28 32 FIGURE 5 The effect of T3 on the accumulation of 3-0-MG by rat thymocytes in vitro. Results represent the pooled data from two experiments in which quadruplicate samples were incubated for each experimental point. Cells were preincubated with T3 (1 nM or 1 ,uM) for 1 h, after which 3H-3-0-MG was added, and its accumulation by cells measured at the indicated intervals thereafter. 12 experiments were then performed in which thymocytes were variously preincubated for 10 min in the absence or presence of puromycin (100 ,guml), and for an additional 1 h in the absence or presence of T3 (1 nM or 1 ,uM), and in which the uptake of 3H-2-DG was then assessed. Puromycin alone produced a significant (P < 0.01), -20%, inhibition of 2-DG uptake (Table II) . Both concentrations of T3 significantly increased 2-DG uptake whether or not puromycin was present, and the percentage stimulation of (Table III) . Dose-response curves for the effect on 3H-2-DG accumulation of several compounds related to T3 revealed the following order of stimulatory potency: T3 > thyroxine (T4) > 3,3',5'-triiodothyronine (rT3) > 3,5-diiodothyronine (3,5-T2) > thyronine (Fig. 6) . Precise quantitative comparisons were not possible because of poor parallelism of dose-response curves.
DISCUSSION
The present studies seem clearly to have shown that, in thymocytes freshly isolated from weanling rats, T3 in vitro stimulates the accumulation of two 3H-labeled analogues of glucose, 2-DG, and 3-0-MG. In the case of 2-DG, this effect of T3 is demonstrable in cells exposed to T3 for a total of only 30 min, i.e., after 15 min of preincubation with T3 and 15 min of incubation with 3H-2-DG. Significant stimulation of 2-DG accumulation was produced by T3 at a concentration of 1 nM, with a linear log dose response up to T3 concentrations of 10 ,uM, at which concentration accumulation of 2-DG was increased by _25%. Although not extensively explored, thyroxine, 3,3',5'-triiodothyronine, and 3,3'-diiodothyronine were also capable of stimulating 2-DG uptake, and the potency of these compounds, relative to that of T3, was similar in rank order to that seen in a variety of other thyroid hormone-responsive systems (see review, reference 21). At concentrations of 1 nM and 1 ,uM, T3 had no effect on the incorporation of [3H]leucine into the protein of thymocytes, even after cells had been preincubated with T3 for as long as 2 h. Moreover, when thymocytes were preincubated with puromycin or cycloheximide at concentrations sufficient to reduce subsequent [3H]leucine incorporation by -95%, basal 2-DG accumulation did decrease, but the proportionate increase in 2-DG accumulation produced by T3 was not altered. Thus, the data strongly indicate that the prompt effect of T3 on 2-DG accumulation is unrelated to any effect on new protein synthesis.
Cellular uptake of 2-DG is the result of two functions, transport of2-DG into the cell and its subsequent phosphorylation by hexokinase. Further metabolism of 2-DG does not occur, and the 2-DG-6-phosphate formed is retained within the cell (22, 23) . At the very low concentration of 2-DG used in the present studies, transport, rather than phosphorylation, is generally the rate-limiting factor in 2-DG accumulation (24, 25) . Hence, it would appear that T3 must have increased 2-DG uptake by increasing its rate of entry into the cell. This conclusion was verified in two sets of ad- (42) .
The major reason to question the physiological relevance of the presently described effect of T3 is the high concentration required to produce this effect, relative to the concentration of the T3 presumed to be acting upon the tissues in the living animal (free T3 concentration =5pM). Although some in vitro effects of T3 are demonstrable at concentrations approaching the physiological, it is often the case that in vitro actions of the thyroid (and other) hormones that appear to have physiological relevance require unphysiologically high concentrations for their prompt in vitro demonstration. For example, in the rat, the lipolytic activity of adipose tissue and the degree to which it is stimulated by epinephrine are clearly influenced by the thyroid state of the animal (see reviews, references [43] [44] [45] [46] . Nevertheless, T3-induced enhancement of these activities in vitro requires concentrations approximately six orders of magnitude greater than the concentration offree T3 presumed to be present in vivo, and three orders of magnitude greater than the concentration of T3 required to produce the effect that we 3Segal, J., C. Ruegsegger, and S. H. Ingbar. Unpublished observations. are describing (47) (48) (49) . A second example is provided by studies that have demonstrated an increase in hepatic mitochondrial protein synthesis after exposure to T3, in which the in vivo sensitivity to this effect was estiimiate(l to be -10,000 times higher than the sensitivity ill vitro (50)-52). Finally, concentrationis of T3 -(100-fold higher than those required to enhanee 2-DG uiptake in thymocytes are necessary to produce inhibition of the adenylate cyclase response to exogenous thyrotropin by bovine thyroid membranes. The concentration of T3 required for the latter effect (50 ,M) is about six orders of magnitude greater than the presumed free T3 concentration in vivo; nevertheless, a seemingly similar inhibition of thyroid a(lenylate cyclase response to exogenous thyrotropin could be produced by the administration of only 2.5 ,ug of T3 to the mouse (53, 54) .
In addition to the requirement that in vitro systemns impose that any effect of T3 be prompt, which might in itself increase the concentration required, in vitro systems are often impaired in the sense that they may lack other factors that act in a permissive, synergistic, or potentiating manner. With respect to the accumulation of 2-DG by rat thymocytes, we have shown that epinephrine and insulin are stimulatory when added alone, and that separately or together they enhance the response to T3. Thus, the minimally effective dose of T3 is reduced by one order of magnitude, i.e., to =0.1 nM, if epinephrine is present in the medium, and is decreased still further (to -10 pM) by the concomitant addition of instulin.3 Hence, under the appropriate conditions, the effect of T3 that we describe can be obtained at concentrations of T3 that are "physiological" or nearly so. Studies carried out in our laboratories and those of our co-workers have defined a number of in vitro effects of T3 that appear to have a strong commonality in respect to their major characteristics. These effects comprise the increase in 2-DG and 3-O-MG transport into rat thymocytes presently described, together with the previously demonstrated increases produced by T3 in 2-DG accumuilation by chick embryo cartilage and nmvocardial cells in cuilture (9) (10) (11) (12) (13) (14) . Two maljor characteristics of these effects are that they are very prompt in onset, being evident froim 1 mimi or less to 30 min after addition of T3, and that they are not blocked by inhibitors of protein synthesis. These properties speak strongly against an action at a nuclear site. Rather, several lines of evidence lead us to suggest that they are mediated at the level of the cell membrane. First, they occur very promptly, as indicated above. Second, they appear to result from changes in functions in which the cell membrane is involved, i.e., inward transport of substrates or their rate of efflux from the cell. Finally, in the rat thymo-cyte, the enhancement of both amino acid4 and 2-DG accumulation that is produced by T3 is further increased by coincubation with beta adrenergic agonists, which themselves are thought to act at the level of the cell membrane. The likelihood that T3 acts directly on the cell inembrane is strengthened by the recent demonstration in plasma membranes from rat hepatocytes of high affinity, low capacity binding sites for T3, whose affinity for other iodothyronines correlates well with their respective hormonal potency (55) . The presence of such sites in the nucleus (1-5) and mitochondrion (8) has been taken to suggest that these are primary sites of T3 action. Nonetheless, it remains to be demonstrated that these sites are indeed linked to hormonal action at the membrane level, including the actions we have described.
